STAT |
Neurotrope Alzheimer's drug data fails to impress; shares plunge
Reuters Neurotrope Inc said on Monday the smaller dose of its experimental Alzheimer's drug met the main goal in a small mid-stage study, but shares tumbled 36 percent in premarket trading as investors were not impressed with the data. In the Neurotrope trial ... Neurotrope misses primary endpoint in Alzheimer's trial In small Alzheimer's study, hints of modest benefit from unusual drug |
from Health - Google News http://ift.tt/2pmZsYX